Zhejiang Yatai Pharmaceutical Co., Ltd. Stock price

Equities

002370

CNE100000MM5

Pharmaceuticals

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
3.49 CNY -3.59% Intraday chart for Zhejiang Yatai Pharmaceutical Co., Ltd. -7.92% -18.65%
Sales 2021 315M 43.6M Sales 2022 373M 51.66M Capitalization 2.64B 365M
Net income 2021 -228M -31.54M Net income 2022 -133M -18.4M EV / Sales 2021 8.12 x
Net Debt 2021 153M 21.21M Net Debt 2022 194M 26.86M EV / Sales 2022 7.59 x
P/E ratio 2021
-10.4 x
P/E ratio 2022
-19.7 x
Employees 531
Yield 2021 *
-
Yield 2022
-
Free-Float 73.59%
More Fundamentals * Assessed data
Dynamic Chart
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Court Orders Bankruptcy Liquidation of Yatai Pharma Unit MT
Yatai Pharma Unit Creditor Seeks Bankruptcy Liquidation MT
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Announces Executive Appointments CI
Yatai Pharmaceutical's Shareholder Plans to Sell 7.27% Stake in the Company CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
More news
1 day-3.59%
1 week-7.92%
Current month+1.45%
1 month-3.06%
3 months-16.51%
6 months-24.13%
Current year-18.65%
More quotes
1 week
3.48
Extreme 3.48
3.92
1 month
3.30
Extreme 3.3
4.00
Current year
2.63
Extreme 2.63
4.38
1 year
2.63
Extreme 2.63
5.28
3 years
2.63
Extreme 2.63
10.20
5 years
2.63
Extreme 2.63
22.15
10 years
2.63
Extreme 2.63
22.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 22-04-14
Director of Finance/CFO 43 22-04-14
Director/Board Member 44 22-04-14
Members of the board TitleAgeSince
Director/Board Member 55 22-04-14
Director/Board Member 57 22-08-24
Director/Board Member 37 22-04-14
More insiders
Date Price Change Volume
24-03-27 3.49 -3.59% 11,315,800
24-03-26 3.62 -3.47% 16,951,360
24-03-25 3.75 +0.27% 25,977,160
24-03-22 3.74 -0.53% 21,766,480
24-03-21 3.76 -0.79% 22,889,520

End-of-day quote Shenzhen S.E., March 26, 2024

More quotes
Zhejiang Yatai Pharmaceutical Co., Ltd. is a China-based company engaged in the manufacture and distribution of drugs. The Company's main business consists of the research, development, production and sales of chemical agents, chemical raw materials and diagnostic reagents, as well as the provision of pharmaceutical research and development outsourcing (CRO) services. The Company's chemical agents are classified as antibiotics and non-antibiotic drugs. Along with its subsidiaries, the Company provides preclinical research services, clinical research services and other advisory services. The Company distributes its products primarily in domestic markets and overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Zhejiang Yatai Pharmaceutical Co., Ltd. - Shenzhen S.E.